ACC/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison

Area of Science:

• Cardiology
• Clinical Practice Guidelines
• Heart Failure Management

Background:

• Current heart failure (HF) management relies on guidelines from the American College of Cardiology/American Heart Association (ACC/AHA) and the European Society of Cardiology (ESC).
• These guidelines provide evidence-based recommendations for diagnosing and treating acute and chronic heart failure (HF).

Purpose of the Study:

• To compare specific recommendations across HF phenotypes and disease severity between ACC/AHA and ESC guidelines.
• To identify differences in recommendations and highlight key studies published since the latest guideline updates.
• To provide a comprehensive overview of current HF management strategies.

Main Methods:

• Comparative analysis of the 2013 ACC/AHA (updated 2016/2017) and 2016 ESC guidelines for heart failure.
• Review of noninvasive and invasive diagnostic testing strategies for HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF).
• Evaluation of evidence supporting guideline-directed medical therapy and device-based therapies for HFrEF and HFpEF.

Main Results:

• Both guidelines address diagnosis and treatment for HFrEF and HFpEF, with stronger evidence for HFrEF management.
• Recommendations cover medical comorbidities, acute HF, and advanced therapies for end-stage disease.
• Key differences in specific recommendations between the guidelines were identified.

Conclusions:

• The review offers a comparative analysis of major HF guidelines to aid clinicians in managing diverse HF patient populations.
• It emphasizes the importance of guideline-directed therapies and identifies areas for future research, particularly for HFpEF.
• Understanding guideline nuances is crucial for optimizing heart failure care.